Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to TradePhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade

Syndax Pharmaceuticals (SNDX) closed the last trading session at $16.33, gaining 63.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet
Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet

Deluxe (DLX) closed the last trading session at $19.66, gaining 26.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's  What You Should Know
Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's What You Should Know

Ranpak Holdings Corp (PACK) closed the last trading session at $5.28, gaining 52.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross

Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke

Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?
Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.52, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade
Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade

Shares of DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) have gained 4.8% over the past four weeks to close the last trading session at $9.65, but there could still be a solid upside left in

Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?

After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pick from a technical perspective. YMAB recently experienced a "golden cross" event, which saw its

Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade
Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade

Shares of ARKO Corp. (ARKO) have gained 25.3% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets

Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?

Arcturus Therapeutics Holdings Inc. (ARCT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ARCT's 50-day simple moving

Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's  What You Should Know
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $5.06, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's  What You Should Know
Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's What You Should Know

Shares of CI&T Inc. (CINT) have gained 2.3% over the past four weeks to close the last trading session at $5.44, but there could still be a solid upside left in the stock if short-term price targets

Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Puma Biotech (PBYI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

The price trend for Puma Biotech (PBYI) has been bearish lately and the stock has lost 12% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session

Here's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock NowPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Here's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now

Shares of Ascentage Pharma Group International - Unsponsored ADR (AAPG) have been struggling lately and have lost 11.3% over the past week. However, a hammer chart pattern was formed in its last

Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now
Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now

Shares of XOMA Royalty (XOMA) have been struggling lately and have lost 5.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the

Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a BetPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet

Shares of Amneal Pharmaceuticals (AMRX) have gained 22.1% over the past four weeks to close the last trading session at $9.56, but there could still be a solid upside left in the stock if short-term

S&T Bancorp (STBA)'s Technical Outlook is Bright After Key Golden Cross
S&T Bancorp (STBA)'s Technical Outlook is Bright After Key Golden Cross

After reaching an important support level, S&T Bancorp, Inc. (STBA) could be a good stock pick from a technical perspective. STBA recently experienced a "golden cross" event, which saw its 50-day

Boeing's Defense Unit Steers to New Heights on Expanding BacklogPhoto, wide shot, wide-angle lens,  Investment company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/81ff9992-3b90-4de2-ac95-7385f4698b55.png
Boeing's Defense Unit Steers to New Heights on Expanding Backlog

The Boeing Company’s (BA) defense business has been a stabilizing pillar for the aerospace giant as its commercial division, despite showing growth traits lately, continues to face supply-chain and

ABT Stock Gains From Navitor's Expanded Indication Approval in Europe
ABT Stock Gains From Navitor's Expanded Indication Approval in Europe

Abbott Laboratories ABT recently received CE Mark in Europe for an expanded indication for its Navitor transcatheter aortic valve implantation (TAVI) system to treat people with symptomatic, severe

TTE & XING Mobility to Unlock High-Growth Battery Cooling Market
TTE & XING Mobility to Unlock High-Growth Battery Cooling Market

TotalEnergies SE TTE announced that TotalEnergies Lubrifiants and XING Mobility have signed a Memorandum of Understanding to jointly promote cutting-edge immersion cooling battery systems. In order

ExxonMobil Flags Coal Comeback as Threat to Net-Zero Goals
ExxonMobil Flags Coal Comeback as Threat to Net-Zero Goals

Exxon Mobil Corporation XOM has issued an update on the future of global emissions, warning that the world’s net-zero targets are increasingly slipping beyond the 2050 horizon, per a Bloomberg

FDA Identifies ICU Medical's Plum Duo Recall as Serious TypePhoto, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
FDA Identifies ICU Medical's Plum Duo Recall as Serious Type

ICU Medical ICUI is currently encountering a recall notice from the FDA for its Plum Duo Infusion System. The recall is for correcting certain devices with software issues, but does not involve

Is Enbridge's Business Vulnerable to Volatility in Oil & Gas Prices?Photo, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Is Enbridge's Business Vulnerable to Volatility in Oil & Gas Prices?

Enbridge Inc. ENB is a leading midstream energy company transporting crude oil and natural gas. Unlike exploration and production companies and refining or downstream players, Enbridge's business

Why Sonic Automotive (SAH) is a Top Momentum Stock for the Long-TermPhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, sunset photo at golden hour, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-ZpZWLOA2q1Lrbc78ceLTs90l.png?st=2023-05-15T05%3A50%3A02Z&se=2023-05-15T07%3A50%3A02Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T21%3A19%3A00Z&ske=2023-05-15T21%3A19%3A00Z&sks=b&skv=2021-08-06&sig=aAZzsKm3Fg0e2CB07XvcACW5j1LlZPrsv8bXoWdHs6k%3D
Why Sonic Automotive (SAH) is a Top Momentum Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Here's Why Synchrony (SYF) is a Strong Momentum Stock
Here's Why Synchrony (SYF) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service